From simple to complex: Hikma’s injectables capabilities uncovered
As one of the world’s largest generic pharmaceutical companies, Hikma operates in North America, the Middle...
Read more
Pharmaceuticals
Novartis weighs major investment in Denton manufacturing plant
Swiss-based Novartis is considering a $280 million investment to build a new manufacturing plant in Denton...
Read more
Why Samsung, Amgen, and Biocon are investing in US pharma facilities
As global trade tensions mount and tariff policy becomes less predictable, international pharmaceutical giants are turning...
Read more
Tariffs trigger a $270B pharma shift back to US production
In 2025, pharmaceutical manufacturers are facing a fundamental disruption. The US government has proposed new tariffs,...
Read more
US Sees Unprecedented $270 Billion in Manufacturing Plans
Fifteen of the world’s leading pharmaceutical companies are collectively investing more than $270 billion into US-based...
Read more